Compounds such as Vinblastine, Nocodazole, Brefeldin A, and Methyl-β-cyclodextrin (MβCD) fall into this category. Vinblastine and Nocodazole disrupt microtubule dynamics, which are crucial for vesicle trafficking, a process Sar1B is heavily involved in. Therefore, these changes in microtubule dynamics due to Vinblastine and Nocodazole can enhance Sar1B's functional activity.
Brefeldin A disrupts the Golgi apparatus and affects vesicle trafficking. As Sar1B plays a key role in this process, its activity could be enhanced by Brefeldin A through its impact on the Golgi and vesicle trafficking. Methyl-β-cyclodextrin (MβCD) depletes cholesterol from the plasma membrane. As Sar1B's function in vesicle trafficking can be influenced by changes in membrane fluidity, its activity can be enhanced by MβCD. Lastly, compounds like Forskolin and 3-Isobutyl-1-methylxanthine (IBMX) increase intracellular cAMP levels, which is known to regulate COPII-mediated vesicle trafficking, a process that Sar1B is involved in. Consequently, an increase in cAMP levels can enhance the functional activity of Sar1B.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is known to activate adenylyl cyclase, leading to an increase in intracellular cAMP levels. Sar1B is involved in COPII-mediated vesicle trafficking, a process that is regulated by cAMP. Therefore, an increase in cAMP levels can enhance the functional activity of Sar1B. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective phosphodiesterase inhibitor that prevents the breakdown of cAMP, leading to an increase in intracellular cAMP levels. As cAMP regulates COPII-mediated vesicle trafficking, a process that Sar1B is involved in, increased levels of cAMP can enhance the functional activity of Sar1B. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is an activator of Protein Kinase C (PKC), which is known to regulate vesicle trafficking. As Sar1B is key in COPII vesicle trafficking, activation of PKC by PMA can enhance the functional activity of Sar1B. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases. The COPII-mediated vesicle trafficking process that Sar1B is involved in can be regulated by phosphorylation. By inhibiting these phosphatases, Okadaic acid can enhance the activity of Sar1B by maintaining its phosphorylation status. | ||||||
Rottlerin | 82-08-6 | sc-3550 sc-3550B sc-3550A sc-3550C sc-3550D sc-3550E | 10 mg 25 mg 50 mg 1 g 5 g 20 g | $84.00 $166.00 $302.00 $2091.00 $5212.00 $16657.00 | 51 | |
Rottlerin is a PKCδ inhibitor. PKCδ is another protein that regulates vesicle trafficking, a process that Sar1B is involved in. By inhibiting PKCδ, Rottlerin can enhance the relative activity of Sar1B by reducing competition for binding sites on the vesicles. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $102.00 $235.00 $459.00 $1749.00 $2958.00 | 4 | |
Vinblastine disrupts microtubule dynamics. Sar1B is known to be associated with vesicle trafficking, which is influenced by microtubule dynamics. Therefore, changes in these dynamics due to Vinblastine can enhance the functional activity of Sar1B. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole disrupts microtubules. As Sar1B is involved in vesicle trafficking, which relies on microtubule dynamics, its activity can be enhanced by influencing these dynamics. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
2-Deoxy-D-glucose inhibits glycolysis and can alter cellular energy status. As Sar1B is ATP-dependent, changes in cellular energy levels can influence its activity. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Chlorpromazine affects clathrin-mediated endocytosis, a process that Sar1B is indirectly involved in as it regulates vesicle trafficking. Therefore, Chlorpromazine can enhance the functional activity of Sar1B. | ||||||
Methyl-β-cyclodextrin | 128446-36-6 | sc-215379A sc-215379 sc-215379C sc-215379B | 100 mg 1 g 10 g 5 g | $20.00 $48.00 $160.00 $82.00 | 19 | |
MβCD depletes cholesterol from the plasma membrane. As Sar1B's function in vesicle trafficking can be influenced by membrane fluidity changes, its activity can be enhanced by MβCD treatment. | ||||||